OOIR: Observatory of International Research

Papers

(The H4-Index of Cardiology in the Young is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)

Article	Citations
Neurodevelopmental evaluation strategies for children with congenital heart disease aged birth through 5 years: recommendations from the cardiac neurodevelopmental outcome collaborative	64
Neurodevelopmental evaluation for school-age children with congenital heart disease: recommendations from the cardiac neurodevelopmental outcome collaborative	49
Nomenclature for Pediatric and Congenital Cardiac Care: Unification of Clinical and Administrative Nomenclature – The 2021 International Paediatric and Congenital Cardiac Code (IPCCC) and the Eleventh	44
Disruptions in the development of feeding for infants with congenital heart disease	34
Neurodevelopmental and psychosocial interventions for individuals with CHD: a research agenda and recommendations from the Cardiac Neurodevelopmental Outcome Collaborative	33
Impact of the COVID-19 pandemic on CHD care and emotional wellbeing	33
Intriguing new faces of Covid-19: persisting clinical symptoms and cardiac effects in children	28
Parent mental health and family functioning following diagnosis of CHD: a research agenda and recommendations from the Cardiac Neurodevelopmental Outcome Collaborative	26
Self-limited myocarditis presenting with chest pain and ST segment elevation in adolescents after vaccination with the BNT162b2 mRNA vaccine	22
Are e-learning Webinars the future of medical education? An exploratory study of a disruptive innovation in the COVID-19 era	21
Webinars reduce the environmental footprint of pediatric cardiology conferences	21
Variations in practice in cardiac neurodevelopmental follow-up programs	21
Characterisation of neurodevelopmental and psychological outcomes in CHD: a research agenda and recommendations from the cardiac neurodevelopmental outcome collaborative	21
The origins and development of the Cardiac Neurodevelopmental Outcome Collaborative: creating innovative clinical, quality improvement, and research opportunities	20
The Fontan outcomes network: first steps towards building a lifespan registry for individuals with Fontan circulation in the United States	20
Treatment strategies for protein-losing enteropathy in Fontan-palliated patients	19
COVID-19 and congenital heart disease: an insight of pathophysiology and associated risks	18
2021 PACES expert consensus statement on the indications and management of cardiovascular implantable electronic devices in pediatric patients	18